Fullerene-porphyrin nanostructures in photodynamic therapy.

Photodynamic therapy represents an alternative treatment with great potential in some types of cancer and premalignant conditions. In the quest to improve this therapy, potential new nontetrapyrrole photosensitizers are currently under research. Hence, in the last few years fullerenes attracted an increased interest because they prove characteristics for nanotechnology's biomedical applications. Fullerenes derivatization for biology application in general and in particular for photodynamic therapy, led to the idea of their association with porphyrins. Porphyrins, well-known players in this domain, could form in association with fullerenes, new compounds with unique properties, namely new photosensitizers with enhanced efficiency in terms of singlet oxygen generation and tumor cell penetration. This article is an attempt to underscore the enormous effort currently dedicated to an emerging field represented by these new nanostructures for biomedicine and in particular for photodynamic therapy.

[1]  N. Jux,et al.  Electrophoresis of electrostatically assembled fullerene-porphyrin conjugates. , 2006, Organic & biomolecular chemistry.

[2]  Pawel L Urban,et al.  Nanoparticles: their potential toxicity, waste and environmental management. , 2009, Waste management.

[3]  Stephen R. Wilson.  Nanomedicine: Fullerene and Carbon Nanotube Biology , 2002 .

[4]  R. Haddon,et al.  Chemically functionalized water soluble single-walled carbon nanotubes modulate neurite outgrowth. , 2005, Journal of nanoscience and nanotechnology.

[5]  R. Seshadri,et al.  SYNTHESIS ROUTES FOR LARGE VOLUMES OF NANOPARTICLES , 2004 .

[6]  T. Webster,et al.  Nanostructured biomaterials for tissue engineering bone. , 2007, Advances in biochemical engineering/biotechnology.

[7]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[8]  Betty Y. S. Kim,et al.  Advances and challenges of nanotechnology-based drug delivery systems , 2007, Expert opinion on drug delivery.

[9]  A. Krokosz.  [Fullerenes in biology]. , 2007, Postepy biochemii.

[10]  V. Mody,et al.  Novel nanomedicine-based MRI contrast agents for gynecological malignancies. , 2009, Advanced drug delivery reviews.

[11]  H. Mukhtar,et al.  Photodynamic therapy in dermatology. , 2000, Journal of the American Academy of Dermatology.

[12]  H. Lui,et al.  Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers. , 2009, Skin therapy letter.

[13]  R. D. Bolskar.  Gadofullerene MRI contrast agents. , 2008, Nanomedicine.

[14]  A. Mikus,et al.  A new approach to the synthesis of porphyrin-fullerene dyads , 2004, Molecular Diversity.

[15]  M. Benedetti,et al.  Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. , 2006, Nano letters.

[16]  Nancy A. Monteiro-Riviere,et al.  Nanotoxicology : characterization, dosing and health effects , 2007 .

[17]  V. Rivarola,et al.  Porphyrin-fullerene C60 Dyads with High Ability to Form Photoinduced Charge-separated State as Novel Sensitizers for Photodynamic Therapy¶ , 2005, Photochemistry and photobiology.

[18]  P. Ajayan,et al.  Microcapsule carbon nanotube devices for therapeutic applications. , 2009, Nanotechnology.

[19]  I. Tan,et al.  Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer? , 2009, Photodiagnosis and photodynamic therapy.

[20]  Photodynamic therapy in dermatology. , 2005, Indian journal of dermatology, venereology and leprology.

[21]  S. Mordon,et al.  Intérêt et place de la thérapie photodynamique en gynécologie , 2007 .

[22]  G. Palumbo.  Photodynamic therapy and cancer: a brief sightseeing tour , 2007, Expert opinion on drug delivery.

[23]  T. Takeya,et al.  Intracellular uptake and photodynamic activity of water-soluble [60]- and [70]fullerenes incorporated in liposomes. , 2008, Chemistry.

[24]  G. Pojana,et al.  Effect-oriented physicochemical characterization of nanomaterials , 2007 .

[25]  S. Mordon,et al.  [The place of photodynamic therapy in gynecology]. , 2007, Gynecologie, obstetrique & fertilite.

[26]  Peter Wick,et al.  Nanomaterial cell interactions: how do carbon nanotubes affect cell physiology? , 2009, Nanomedicine.

[27]  R. Zand,et al.  Spectroscopic Studies of Fullerene Aggregates , 1998 .

[28]  J. Nierengarten,et al.  Fullerenes : principles and applications , 2007 .

[29]  M. Salvatore,et al.  Nuclear imaging in cancer theranostics. , 2007, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[30]  Review of photodynamic therapy. , 2006, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[31]  Michael R Hamblin,et al.  Photodynamic therapy with fullerenes , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[32]  R. Ion,et al.  Porphyrin - Based Supramolecular Nanotubes Generated by Aggregation Processes , 2008 .

[33]  Stanley B. Brown,et al.  The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.

[34]  T. Maisch.  A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment. , 2009, Mini reviews in medicinal chemistry.

[35]  Petras Juzenas,et al.  Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. , 2008, Advanced drug delivery reviews.

[36]  Y. Pathak,et al.  Nanoparticulate Drug Delivery Systems , 2007 .

[37]  R. Haddon,et al.  A Bone Mimic Based on the Self-Assembly of Hydroxyapatite on Chemically Functionalized Single-Walled Carbon Nanotubes , 2005 .

[38]  Michael R Hamblin,et al.  Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. , 2007, Free radical biology & medicine.

[39]  Mark Emberton,et al.  Photodynamic therapy for prostate cancer—a review of current status and future promise , 2009, Nature Clinical Practice Urology.

[40]  Thomas A. Moore,et al.  Mimicking bacterial photosynthesis , 1998 .

[41]  Andrew D. Maynard,et al.  Nanotoxicology: Laying a Firm Foundation for Sustainable Nanotechnologies , 2007 .

[42]  S. Rezayat,et al.  The porphyrin-fullerene nanoparticles to promote the ATP overproduction in myocardium: 25Mg2+-magnetic isotope effect. , 2009, European journal of medicinal chemistry.

[43]  F. Moussa,et al.  Toxicity studies of fullerenes and derivatives. , 2007, Advances in experimental medicine and biology.

[44]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[45]  Alexandra Shulman-Peleg,et al.  Interaction of c(60)-fullerene and carboxyfullerene with proteins: docking and binding site alignment. , 2006, Bioconjugate chemistry.

[46]  A. Moore,et al.  Photoinduced Charge Separation and Charge Recombination to a Triplet State in a Carotene−Porphyrin−Fullerene Triad , 1997 .

[47]  B. Badie,et al.  Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model , 2009, Journal of Neuroimmunology.

[48]  Andrew D. Maynard,et al.  Phospholipid lung surfactant and nanoparticle surface toxicity: Lessons from diesel soots and silicate dusts , 2006 .

[49]  Hui Hu,et al.  Chemically Functionalized Carbon Nanotubes as Substrates for Neuronal Growth. , 2004, Nano letters.

[50]  Paul Debbage,et al.  Targeted drugs and nanomedicine: present and future. , 2009, Current pharmaceutical design.

[51]  T. Hasan,et al.  Strategies for Enhanced Photodynamic Therapy Effects † , 2007, Photochemistry and photobiology.

[52]  Meenakshi Sharma,et al.  Metalloporphyrins—Applications and clinical significance , 2000, Indian Journal of Clinical Biochemistry.

[53]  Arvind Agarwal,et al.  Plasma-sprayed carbon nanotube reinforced hydroxyapatite coatings and their interaction with human osteoblasts in vitro. , 2007, Biomaterials.

[54]  K. Takeda,et al.  Attenuation of delayed-type hypersensitivity by fullerene treatment. , 2009, Toxicology.

[55]  K. Jain.  Role of Nanobiotechnology in the Development of Nanomedicine , 2007 .

[56]  Werner Jaschke,et al.  Molecular imaging with nanoparticles: giant roles for dwarf actors , 2008, Histochemistry and Cell Biology.

[57]  R. Moy,et al.  Photodynamic Therapy for the Treatment of Cutaneous Neoplasia, Inflammatory Disorders, and Photoaging , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[58]  Z. Marković,et al.  Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). , 2008, Biomaterials.

[59]  P. Alvarez,et al.  Mechanisms of photochemistry and reactive oxygen production by fullerene suspensions in water. , 2008, Environmental science & technology.

[60]  Robert L. Tanguay,et al.  In vivo evaluation of carbon fullerene toxicity using embryonic zebrafish. , 2007, Carbon.

[61]  Masaru Mukai,et al.  Photodynamic activity of C70 caged within surface-cross-linked liposomes. , 2009, Chemistry, an Asian journal.

[62]  G. Manda,et al.  Synthetic porphyrins in experimental photodynamic therapy induce a different antitumoral effect , 2007 .

[63]  L. Ferreira,et al.  Nanoparticles as tools to study and control stem cells , 2009, Journal of cellular biochemistry.

[64]  M R Wiesner,et al.  Fullerol-sensitized production of reactive oxygen species in aqueous solution. , 2005, Environmental science & technology.

[65]  Seiji Taniguchi,et al.  Linkage and Solvent Dependence of Photoinduced Electron Transfer in Zincporphyrin-C60 Dyads , 1996 .

[66]  J. Sanders,et al.  Supramolecular assemblies of tripodal porphyrin hosts and C60. , 2008, Chemistry.

[67]  M. Wiesner,et al.  Comparison of electrokinetic properties of colloidal fullerenes (n-C60) formed using two procedures. , 2005, Environmental science & technology.

[68]  Zhuo Georgia Chen,et al.  Advances of cancer therapy by nanotechnology. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.

[69]  V. Rivarola,et al.  Photodynamic activity of a new sensitizer derived from porphyrin-C60 dyad and its biological consequences in a human carcinoma cell line. , 2006, The international journal of biochemistry & cell biology.

[70]  M. Rusckowski,et al.  Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[71]  Rajesh Singh,et al.  Nanoparticle-based targeted drug delivery. , 2009, Experimental and molecular pathology.

[72]  Bogdan Belgorodsky,et al.  Biodelivery of a fullerene derivative. , 2007, Bioconjugate chemistry.